UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021
Go back to UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021| (NYSE: UCB) | Delayed: 36.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.74 | 52 Week High | $ | |||
| Open | $36.74 | 52 Week Low | $ | |||
| Day High | $36.74 | P/E | N/A | |||
| Day Low | $36.74 | EPS | $ | |||
| Volume | 325 | |||||
| UCB Unsponsored ADR (AMEX: UCBJY) | Delayed: 122.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $122.60 | 52 Week High | $46.25 | |||
| Open | $122.60 | 52 Week Low | $32.74 | |||
| Day High | $122.60 | P/E | N/A | |||
| Day Low | $122.60 | EPS | $0.00 | |||
| Volume | 10 | |||||
